SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Medical technology company Davion Healthcare Plc (DAVI.US) debuts on the U.S. stock market, with its share price falling more than 12% after the opening.
US Stock Market Move | Lockheed Martin Corporation (LMT.US) rose more than 6% as Q3 revenue grew 11% year-over-year and the company raised its full-year guidance.
NVIDIA Corporation (NVDA.US) GTC Berlin signals 2027 growth! Morgan Stanley positive on supply chain expansion and AI factory efficiency gains, reiterates top pick.
US Stock Market Move | Medical technology company Davion Healthcare Plc (DAVI.US) debuts on the U.S. stock market, with its share price falling more than 12% after the opening.
US Stock Market Move | Lockheed Martin Corporation (LMT.US) rose more than 6% as Q3 revenue grew 11% year-over-year and the company raised its full-year guidance.
NVIDIA Corporation (NVDA.US) GTC Berlin signals 2027 growth! Morgan Stanley positive on supply chain expansion and AI factory efficiency gains, reiterates top pick.
